Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register today!

Click here to register today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meroni, P L
Right arrow Articles by Caruso, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meroni, P L
Right arrow Articles by Caruso, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 13, No. 9, 649-652 (2004)
DOI: 10.1191/0961203304lu2001oa
© 2004 SAGE Publications

Antiphospholipid antibodies as cause of pregnancy loss

P L Meroni

Allergy, Clinical Immunology and Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Department of Internal Medicine, University of Milan, Milan, Italy, pierluigi.meroni{at}unimi.it

N di Simone

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

C Testoni

Allergy, Clinical Immunology and Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Department of Internal Medicine, University of Milan, Milan, Italy

M D’Asta

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

B Acaia

Division of Obstetrics and Gynecology, ICP, Milan, Italy

A Caruso

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

Antiphospholipid antibodies detected by lupus anticoagulant, anticardiolipin or anti-beta2 glycoprotein I assays were associated with fetal loss. Rather than being diagnostic tools only, antiphospholipid antibodies are thought to be pathogenic. The strongest demonstration of their pathogenic role lies in the ability to induce fetal resorptions - the experimental equivalents of the human fetal losses - when passively infused in pregnant naive animals. However, still debated is how the antibodies might induce the obstetrical manifestations. Thrombotic events at the placental levels might be related to endothelial cell activation, inhibition of protein C/S system and fibrinolysis as well as to Annexin V displacement. However, the thrombophilic state apparently cannot explain all the miscarriages and a direct antibody-mediated damage on the trophoblast has been suggested. During differentiation to syncytium, trophoblasts express cell membrane anionic phospholipids that can bind beta2 glycoprotein I, the main cationic phospholipid binding protein recognized by the antiphospholipid antibodies. Adhered b2-glycoprotein I might be recognized by the antibodies that, once bound, strongly interfere with in vitro trophoblast cell maturation so resulting in a defective placentation. These mechanisms have been suggested to play a role in early fetal loss, while thrombotic events would be responsible for miscarriages late in the pregnancy.

Key Words: antiphospholipid antibodies • fetal loss • trophoblast


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Martinez de la Torre, C. Buracchi, E. M. Borroni, J. Dupor, R. Bonecchi, M. Nebuloni, F. Pasqualini, A. Doni, E. Lauri, C. Agostinis, et al.
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6
PNAS, February 13, 2007; 104(7): 2319 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. DI SIMONE, R. CASTELLANI, E. RASCHI, M. ORIETTA BORGHI, P. L. MERONI, and A. CARUSO
Anti-Beta-2 Glycoprotein I Antibodies Affect Bcl-2 and Bax Trophoblast Expression without Evidence of Apoptosis
Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 364 - 376.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
F. A. Hills, V. M. Abrahams, B. Gonzalez-Timon, J. Francis, B. Cloke, L. Hinkson, R. Rai, G. Mor, L. Regan, M. Sullivan, et al.
Heparin prevents programmed cell death in human trophoblast
Mol. Hum. Reprod., April 1, 2006; 12(4): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Tincani, D Bompane, E Danieli, and A Doria
Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome)
Lupus, March 1, 2006; 15(3): 156 - 160.
[Abstract] [PDF]